Altered phosphorylation patterns of some proteins may have implications for sporadic Alzheimer disease.
The researchers sought to understand the prognostic value of tau positron emission tomography for predicting cognitive decline across the clinical spectrum of Alzheimer disease.
DA01 is an investigational pluripotent stem cell-derived dopaminergic neuron therapy designed to replace the midbrian dopaminergic neurons lost in Parkinson disease.
For patients with dementia-related psychosis who have a response to pimavanserin, the risk for relapse is lower with continuation of the drug versus discontinuation
The review authors sought to elucidate the neurological harms of methamphetamine, which are well-documented but poorly understood.
The overall global age-standardized prevalence of young-onset dementia, in which symptoms start before age 65 years, is 119.0 per 100,000 population.
This phase 2, double-blind trial of solriamfetol evaluated the dose-dependent effects on sleep latency in patients with Parkinson disease.
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion
The researchers conducted a randomized, placebo-controlled, multi-arm trial of gantenerumab or solanezumab in participants with dominantly inherited Alzheimer disease across asymptomatic and symptomatic disease stages.
Study researchers examined the different paradigms on the pathophysiology of MS, the outside-in and the inside-out theories.